The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II clinical trial of NY-ESO-1-specific TCR-engineered T-cell transfer combined with a novel T-cell stimulator CHP:NE1 for patients with refractory soft tissue sarcoma.
 
Mikiya Ishihara
Honoraria - Chugai Pharma; Eisai; MSD; Pfizer; Takara Bio
Research Funding - Takara Bio (Inst); United Immunity (Inst)
 
Hiroyoshi Hattori
Employment - GlaxoSmithKline (I)
 
Eisuke Arai
No Relationships to Disclose
 
Yoshihiro Nishida
Honoraria - Daiichi Sankyo; Eisai; Ono Pharmaceutical
Consulting or Advisory Role - Seikagaku
Speakers' Bureau - Chugai Pharma
Research Funding - Novartis
 
Kohichi Takada
No Relationships to Disclose
 
Makoto Emori
No Relationships to Disclose
 
Akira Kawai
Honoraria - Eisai; Lilly; Novartis; Taiho Pharmaceutical; Takara Bio
 
Takafumi Ueda
Consulting or Advisory Role - Daiichi Sankyo; Eisai
Research Funding - Eisai; Lilly Japan; Taiho Pharmaceutical; Takara Bio
 
Makoto Endo
Honoraria - Taisho Toyama Pharma
Consulting or Advisory Role - Eisai; Lilly
Speakers' Bureau - Daiichi Sankyo; Eisai; Novartis
 
Yoshihiro Matsumoto
Honoraria - Eisai
 
Tetsuro Sasada
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Nippon Kayaku
Research Funding - BrightPath Biotheraputics (Inst); Taiho Pharmaceutical (Inst)
 
Eiichi Sato
Expert Testimony - Takara Bio
 
Tomomi Yamada
No Relationships to Disclose
 
Akihiko Matsumine
Consulting or Advisory Role - Takara Bio
Speakers' Bureau - Asahi Kasei; Astellas Pharma; AYUMI; Daiichi Sankyo; Eisai; Hisamitsu Pharmaceutical; Lilly; Nihon Zouki; Pfizer; Taisho Toyama Pharma
 
Yasuhiro Nagata
No Relationships to Disclose
 
Naozumi Harada
Leadership - United Immunity
Stock and Other Ownership Interests - United Immunity
Research Funding - Chugai Pharma (Inst)
 
Hiroshi Shiku
Research Funding - Takara Bio (Inst)
Patents, Royalties, Other Intellectual Property - Takara Bio
 
Shinichi Kageyama
Honoraria - Kyowa Hakko Kirin; Sumitomo Dainippon; Takara Bio
Consulting or Advisory Role - Takara Bio
Speakers' Bureau - Kyowa Hakko Kirin; Sumitomo Dainippon
Research Funding - Takara Bio (Inst); United Immunity (Inst)
Travel, Accommodations, Expenses - Kyowa Hakko Kirin; Sumitomo Dainippon; Takara Bio